Cogstate Ltd
Company Profile
Business description
Cogstate Ltd is engaged in the creation, validation, and commercialisation of digital brain health assessments and the design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its solutions include Digital Cognitive Assessment, Endpoint Data Quality, Remote Assessment and Healthcare Cognitive Screening. Its operating segments are Clinical Trials, Healthcare, and Administration, with Clinical Trials generating maximum revenue. The Group provides licensed software to Clinical Trials and Healthcare customers, comprising access to the software.
Contact
367 Collins Street
Level 32
MelbourneVIC3000
AUST: +61 396641300
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
Employees
249
Stocks News & Analysis
stocks
CBA earnings: Business lending powers on, but costs and credit bear watching
stocks
Apple earnings review: Revenue beats estimates as memory crunch threatens margins
stocks
Nvidia: Cutting our fair value estimate by 19% given the firm’s CEO transition and turmoil
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,204.50 | 69.70 | -0.75% |
| CAC 40 | 8,368.91 | 7.55 | 0.09% |
| DAX 40 | 26,749.95 | 21.93 | -0.08% |
| Dow JONES (US) | 52,347.55 | 50.46 | 0.10% |
| FTSE 100 | 10,902.56 | 39.47 | 0.36% |
| HKSE | 23,637.60 | 370.95 | -1.55% |
| NASDAQ | 25,136.27 | 229.82 | -0.91% |
| Nikkei 225 | 61,142.35 | 322.99 | 0.53% |
| NZX 50 Index | 14,173.68 | 85.55 | -0.60% |
| S&P 500 | 7,561.67 | 30.73 | -0.40% |
| S&P/ASX 200 | 9,082.20 | 64.60 | -0.71% |
| SSE Composite Index | 3,634.35 | 21.48 | -0.59% |